# A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris

> **NCT03615768** · PHASE3 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 1617 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **COMBINATION_PRODUCT:** Adapalene-Clindamycin Combination Gel
- **DRUG:** Adapalene Gel
- **DRUG:** Clindamycin Gel

## Key facts

- **NCT ID:** NCT03615768
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-14
- **Primary completion:** 2020-02-13
- **Final completion:** 2020-04-07
- **Target enrollment:** 1617 (ACTUAL)
- **Last updated:** 2020-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615768, "A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03615768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
